East-west Global Initiatives In Regulated R&D Programs | 18745
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 3463

Journal of Analytical & Bioanalytical Techniques received 3463 citations as per Google Scholar report

Journal of Analytical & Bioanalytical Techniques peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • OCLC- WorldCat
  • Scholarsteer
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Euro Pub
Share This Page

East-west global initiatives in regulated R&D programs

5th International Conference and Exhibition on Analytical & Bioanalytical Techniques

Michael Zhou

Accepted Abstracts: J Anal Bioanal Tech

DOI: 10.4172/2155-9872.S1.019

Pharmaceutical industry has led global initiatives to develop consensus around acceptable benchmark practices applicable to standardizing laboratory and good management systems for regulated R&D programs. Collaboration between West and East has become increasingly important for the quality of data, implementations, and products approved for public use by regulatory agencies worldwide. In this presentation, historical background and current progress on regulated bioanalysis for preclinical and clinical research will be discussed. Ongoing activities regarding continuous improvement of quality from technical and regulatory perspectives will be described using typical case studies (i.e., how to establish robust and high quality bioanalytical methods based on emerging techniques and approaches). The presentation will conclude by outlining future trends in this field for which successful implementation and execution is expected to improve quality and consistency for clinical bioanalysis from global perspectives.